TKT and breast carcinoma: Many regulatory factors, such as siRNA [152], pDNA [156], microRNA-101 (miR-101) [153]and the herpes simplex virus thymidine kinase gene (HSV-TK) [139] have been used in graphene-based gene therapy for breast cancer treatment.